Bone and Mineral Metabolism and Fibroblast Growth Factor 23 Levels After Kidney Donation

The FGF-23 pathway may be activated in living kidney donors who show early biochemical changes compatible with chronic kidney disease-mineral and bone disorder. Whether these changes influence bone mineral density and fracture rates warrants consideration.